ICU Medical, Inc.ICUINASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 82% recommend buying.

Consensus Rating
Buy
11 analysts·Moderate coverage
82%
Rating Distribution
Strong Buy
19%
Buy
873%
Hold
218%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 9% higher.

Bear Case
$153.00
+2%
Consensus
$163.00
+9%
Bull Case
$173.00
+15%
Price Range11 analysts
Low
Consensus
High
$153.00
$173.00
Current Target
Current Price
$149.90
Upside to Target
$13.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 21, 2025KeyBanc
ICU Medical price target lowered to $173 from $191 at KeyBanc
Target:$173.00
+47.4%from $117.34
Sep 10, 2025Piper Sandler
ICU Medical price target raised to $153 from $145 at Piper Sandler
Target:$153.00
+15.3%from $132.74
Aug 15, 2025Piper Sandler
Piper Sandler bullish on ICU Medical, initiates with an Overweight
Target:$145.00
+21.5%from $119.32
Mar 12, 2025Raymond James
ICU Medical upgraded to Strong Buy from Outperform at Raymond James
Target:$97.00
-30.2%from $138.99
Oct 15, 2024KeyBanc
ICU Medical price target raised to $198 from $147 at KeyBanc
Target:$198.00
+9.8%from $180.30
Oct 14, 2024Jefferies
Jefferies Starts ICU Medical (ICUI) at Hold
Target:$183.00
+2.4%from $178.72
Jun 17, 2024Raymond James
Raymond James Upgrades ICU Medical (ICUI) to Outperform
Target:$135.00
+15.0%from $117.44
Aug 9, 2022Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $190
Target:$190.00
+1.0%from $188.10
Aug 8, 2022Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $208
Target:$208.00
+15.8%from $179.63
May 10, 2022Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $235
Target:$235.00
+16.8%from $201.17